BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7784896)

  • 1. [Fate of human fetal dopamine neurons transplanted into rhesus monkey model of Parkinson's disease: a tyrosine hydroxylase immunocytochemical study].
    Jiang ZH; Liu ZG; Chen SD; Zhou WB; Cai J; Ni ZM; Zhou CF
    Sheng Li Xue Bao; 1995 Feb; 47(1):31-7. PubMed ID: 7784896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrastriatal and intranigral grafting of hNT neurons in the 6-OHDA rat model of Parkinson's disease.
    Baker KA; Hong M; Sadi D; Mendez I
    Exp Neurol; 2000 Apr; 162(2):350-60. PubMed ID: 10739641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Behaviour after transplantation of brain cells into monkey models of Parkinson's disease].
    Liu ZG; Chen S; Yu H
    Zhonghua Yi Xue Za Zhi; 1997 Sep; 77(9):683-6. PubMed ID: 9772539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Agrawal AK
    Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study.
    Mendez I; Elisevich K; Flumerfelt B
    J Comp Neurol; 1991 Jun; 308(1):66-78. PubMed ID: 1714923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry.
    Clarke DJ; Brundin P; Strecker RE; Nilsson OG; Björklund A; Lindvall O
    Exp Brain Res; 1988; 73(1):115-26. PubMed ID: 3145209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonic substantia nigra grafts show directional outgrowth to cografted striatal grafts and potential for pathway reconstruction in nonhuman primate.
    Sladek JR; Bjugstad KB; Collier TJ; Bundock EA; Blanchard BC; Elsworth JD; Roth RH; Redmond DE
    Cell Transplant; 2008; 17(4):427-44. PubMed ID: 18522245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
    Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
    Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intracerebral transplantation of nerve cells and genetically modified cells for disorders of central nervous system, a basic and clinical study].
    Wu C; Liu Y; Wang J; Yang Y; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(7):440-4. PubMed ID: 12133510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease.
    Kordower JH; Freeman TB; Chen EY; Mufson EJ; Sanberg PR; Hauser RA; Snow B; Olanow CW
    Mov Disord; 1998 May; 13(3):383-93. PubMed ID: 9613726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease.
    Agrawal AK; Chaturvedi RK; Shukla S; Seth K; Chauhan S; Ahmad A; Seth PK
    J Chem Neuroanat; 2004 Dec; 28(4):253-64. PubMed ID: 15531136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efferent synaptic connections of grafted dopaminergic neurons reinnervating the host neostriatum: a tyrosine hydroxylase immunocytochemical study.
    Freund TF; Bolam JP; Björklund A; Stenevi U; Dunnett SB; Powell JF; Smith AD
    J Neurosci; 1985 Mar; 5(3):603-16. PubMed ID: 2857778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey.
    Smith Y; Bennett BD; Bolam JP; Parent A; Sadikot AF
    J Comp Neurol; 1994 Jun; 344(1):1-19. PubMed ID: 7914894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts.
    Emgård M; Karlsson J; Hansson O; Brundin P
    Exp Neurol; 1999 Nov; 160(1):279-88. PubMed ID: 10630212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for target-specific outgrowth from subpopulations of grafted human dopamine neurons.
    Strömberg I; Törnqvist N; Johansson S; Bygdeman M; Almqvist PM
    Microsc Res Tech; 2001 Sep; 54(5):287-97. PubMed ID: 11514985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.